ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
2,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
4,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
4,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
4,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
5,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5,4,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
5,5,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5,6,Headache,Headaches NEC,Headaches,Nerv,N
5,7,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
5,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
5,9,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
5,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
5,11,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
6,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
6,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
7,1,Acne,Acnes,Skin appendage conditions,Skin,N
8,1,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
8,2,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
8,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
8,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
8,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
9,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
9,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
11,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
11,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
12,1,Headache,Headaches NEC,Headaches,Nerv,N
13,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
13,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
13,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
14,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
14,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
15,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
15,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
15,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
16,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
17,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
17,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
17,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
17,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
17,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
17,6,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
18,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
18,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
18,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
19,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
19,2,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
19,3,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
19,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
19,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
20,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
20,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
20,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
20,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
21,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
21,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
22,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
22,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
22,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
23,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
24,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
24,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
24,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
25,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
25,2,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
25,3,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
26,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
26,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
26,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
26,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
27,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
28,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
28,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
29,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
29,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
30,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
30,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
31,1,Cluster headache,Headaches NEC,Headaches,Nerv,N
32,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
32,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
32,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
32,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
32,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
33,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
34,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
35,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
36,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
37,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
38,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
38,2,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
38,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
39,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
39,2,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
39,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
39,4,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
40,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
41,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
42,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
43,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
43,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
43,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
44,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
44,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
45,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
46,1,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
47,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
47,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
47,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
48,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
49,1,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
50,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
51,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
52,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
53,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
54,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
54,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
55,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
55,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
55,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
56,1,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
56,2,Injection site eczema,Injection site reactions,Administration site reactions,Genrl,N
56,3,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
56,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
57,1,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
57,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
58,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
58,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
58,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
58,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
60,1,Gastrointestinal carcinoma,Gastrointestinal neoplasms malignant NEC,Gastrointestinal neoplasms malignant and unspecified,Neopl,N
61,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
61,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
62,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
63,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
63,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
63,3,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
63,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
63,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
64,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
64,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
64,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
65,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
65,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
65,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
65,4,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
65,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
66,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
66,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
66,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
67,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
67,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
67,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
68,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
68,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
68,3,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
68,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
69,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
70,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
70,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
70,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
70,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
71,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
72,1,Anticoagulation drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
72,2,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
73,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
73,2,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
73,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
73,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
73,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
73,6,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
74,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
74,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
74,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
74,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
74,5,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
74,6,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
74,7,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
75,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
75,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
75,3,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
75,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
75,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
76,1,Headache,Headaches NEC,Headaches,Nerv,N
77,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
77,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
78,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
79,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
79,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
79,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
80,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
80,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
80,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
80,4,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
81,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
81,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
81,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
81,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
81,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
82,1,Hepatic cirrhosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
82,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
83,1,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
83,2,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
84,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
85,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
85,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
86,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
87,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
87,2,Oedema mouth,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
87,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
88,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
89,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
89,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
90,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
90,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
90,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
90,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
91,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
91,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
92,1,Migraine,Migraine headaches,Headaches,Nerv,N
92,2,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
92,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
93,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
93,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
93,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
94,1,Headache,Headaches NEC,Headaches,Nerv,N
95,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
96,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
96,2,Gastroenteritis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,Y
96,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
97,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
98,1,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
99,1,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
99,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
99,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
99,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
99,5,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
100,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
100,2,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
100,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
100,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
100,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
101,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
102,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
103,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
103,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
103,4,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
103,5,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
104,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
104,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
104,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
104,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
104,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
105,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
105,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
106,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
107,1,Headache,Headaches NEC,Headaches,Nerv,N
108,1,Headache,Headaches NEC,Headaches,Nerv,N
109,1,Pancreatic mass,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
110,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
110,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
110,3,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
110,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
110,5,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
110,6,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
110,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
110,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,9,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
111,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
112,1,Lipoatrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
113,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
113,2,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
114,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
114,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
114,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
115,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
116,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
117,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
118,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
118,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
118,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
118,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
118,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
118,6,Fluid intake reduced,Fluid intake decreased,Electrolyte and fluid balance conditions,Metab,N
119,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
119,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
120,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
120,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
120,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
120,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
120,5,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
121,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
121,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
122,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
122,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
123,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
124,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
125,1,Abdominal rigidity,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
126,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
126,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
126,3,Myalgia,Muscle pains,Muscle disorders,Musc,N
126,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
127,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
127,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
127,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
127,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
128,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
129,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
129,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
129,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
129,4,Headache,Headaches NEC,Headaches,Nerv,N
129,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
130,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
130,2,Glycosylated haemoglobin increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
131,1,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
131,2,Intestinal mass,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
131,3,Obstruction gastric,Gastric and pyloric stenosis and obstruction,Gastrointestinal stenosis and obstruction,Gastr,N
132,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
132,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
132,3,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
132,4,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
132,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
132,6,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
132,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
132,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
132,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
132,10,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
132,11,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
132,12,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
132,13,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
132,14,Migraine,Migraine headaches,Headaches,Nerv,N
132,15,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
132,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
132,17,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
132,18,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
132,19,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
132,20,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
132,21,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
132,22,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
133,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
133,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
133,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
134,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
135,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
135,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
136,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
137,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
137,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
138,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
138,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
138,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
139,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
139,2,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
139,3,Impaired gastric emptying,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
139,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
139,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
139,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
139,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
139,8,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
140,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
140,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
141,1,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
141,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
142,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
142,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
143,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
144,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
144,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
145,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
145,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
145,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
146,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
146,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
146,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
146,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
147,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
147,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
147,3,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
147,4,Oral mucosal erythema,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
148,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
149,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
150,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
150,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
151,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
151,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
152,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
152,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
153,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
153,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
153,3,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
153,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
153,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
153,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
153,7,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
153,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
153,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
154,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
154,2,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
155,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
155,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
156,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
156,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
156,3,Postictal state,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
156,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
156,5,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
157,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
157,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
158,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
159,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
159,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
159,3,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
159,4,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
159,5,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
159,6,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
159,7,Retching,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
159,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
160,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
160,2,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
160,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
160,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
160,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
160,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
161,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
162,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
163,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
163,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
163,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
163,4,Ocular hyperaemia,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
163,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
163,6,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
163,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
164,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
165,1,Local reaction,General signs and symptoms NEC,General system disorders NEC,Genrl,N
166,1,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
167,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
168,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
169,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
170,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
171,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
171,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
172,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
172,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
172,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
172,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
172,5,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
173,1,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
174,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
175,1,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
176,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
176,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
177,1,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
177,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
178,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
178,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
178,3,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
179,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
179,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
180,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
180,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
180,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
181,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
181,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
182,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
182,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
183,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
183,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
184,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
184,2,Migraine,Migraine headaches,Headaches,Nerv,N
185,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
186,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
186,2,Pancreatitis acute,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
187,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
187,2,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
188,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
188,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
189,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
189,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
189,3,Biliary sepsis,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
189,4,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
189,5,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
189,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
189,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
189,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
190,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
190,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
190,3,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
191,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
192,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
192,2,Headache,Headaches NEC,Headaches,Nerv,N
192,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
192,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
192,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
192,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
192,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
193,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
193,2,Pancreatic carcinoma,Pancreatic neoplasms malignant (excl islet cell and carcinoid),Gastrointestinal neoplasms malignant and unspecified,Neopl,N
194,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
195,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
195,2,Headache,Headaches NEC,Headaches,Nerv,N
195,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
195,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
196,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
197,1,Headache,Headaches NEC,Headaches,Nerv,N
197,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
197,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
198,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
198,2,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
198,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
199,1,Deprescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
199,2,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
200,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
201,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
201,2,Device issue,Device issues NEC,Device issues,Prod,N
201,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
201,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
202,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
203,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
203,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
204,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
